Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 7:50 pm Sale |
2021-12-31 | 13G | Duos Technologies Group, Inc. DUOT |
LYTTON LAURENCE W | 214,700 5.900% |
-1,000 (-0.46%) |
Filing History |
| 2022-02-14 7:45 pm Purchase |
2021-12-31 | 13G | Giga-tronics Incorporated GIGA |
LYTTON LAURENCE W | 274,951 9.990% |
27,251 (+11.00%) |
Filing History |
| 2022-02-14 7:44 pm Sale |
2021-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
LYTTON LAURENCE W | 417,779 6.600% |
-56,621 (-11.94%) |
Filing History |
| 2021-12-30 12:27 pm Purchase |
2021-12-20 | 13G | LiqTech International, Inc. LIQT |
LYTTON LAURENCE W | 276,247 10.400% |
35,974 (+14.97%) |
Filing History |
| 2021-10-06 4:19 pm Purchase |
2021-09-26 | 13G | DiaMedica Therapeutics Inc. DMAC |
LYTTON LAURENCE W | 1,380,266 5.200% |
1,380,266 (New Position) |
Filing History |
| 2021-03-05 7:26 pm Purchase |
2021-02-25 | 13G | Cidara Therapeutics, Inc. CDTX |
LYTTON LAURENCE W | 167,020 7.000% |
30,666 (+22.49%) |
Filing History |
| 2021-03-05 4:55 pm Purchase |
2021-02-25 | 13G | Cidara Therapeutics, Inc. CDTX |
LYTTON LAURENCE W | 136,354 5.700% |
136,354 (New Position) |
Filing History |
| 2021-02-16 12:24 pm Sale |
2020-12-31 | 13G | Chembio Diagnostics, Inc. CEMI |
LYTTON LAURENCE W | 0 0.000% |
-1,010,718 (Position Closed) |
Filing History |
| 2021-02-16 11:46 am Purchase |
2020-12-31 | 13G | VERTEX ENERGY INC VTNRQ |
LYTTON LAURENCE W | 4,093,561 9.000% |
4,093,561 (New Position) |
Filing History |
| 2021-02-16 11:43 am Purchase |
2020-12-31 | 13G | Ra Medical Systems, Inc. RMED |
LYTTON LAURENCE W | 4,819 7.700% |
4,819 (New Position) |
Filing History |
| 2021-02-16 11:39 am Sale |
2020-12-31 | 13G | LiqTech International, Inc. LIQT |
LYTTON LAURENCE W | 240,273 8.700% |
-31,963 (-11.74%) |
Filing History |
| 2021-02-16 11:37 am Purchase |
2020-12-31 | 13G | HTG Molecular Diagnostics, Inc. HTGM |
LYTTON LAURENCE W | 40,368 9.990% |
40,368 (New Position) |
Filing History |
| 2021-02-16 11:34 am Purchase |
2020-12-31 | 13G | Giga-tronics Incorporated GIGA |
LYTTON LAURENCE W | 247,700 9.400% |
1,900 (+0.77%) |
Filing History |
| 2021-02-16 11:32 am Sale |
2020-12-31 | 13G | EMCORE Corporation EMKR |
LYTTON LAURENCE W | 171,830 5.800% |
-104,058 (-37.72%) |
Filing History |
| 2021-02-16 11:30 am Sale |
2020-12-31 | 13G | Duos Technologies Group, Inc. DUOT |
LYTTON LAURENCE W | 215,700 6.100% |
-67,300 (-23.78%) |
Filing History |
| 2021-02-16 11:26 am Purchase |
2020-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
LYTTON LAURENCE W | 474,400 9.990% |
234,138 (+97.45%) |
Filing History |
| 2021-02-16 11:22 am Sale |
2020-12-31 | 13G | Apollo Endosurgery, Inc. APEN |
LYTTON LAURENCE W | 2,648,150 9.990% |
-17,782 (-0.67%) |
Filing History |
| 2021-01-04 12:35 pm Purchase |
2020-12-22 | 13G | SUNESIS PHARMACEUTICALS INC CO SNSS |
LYTTON LAURENCE W | 1,598,519 8.800% |
1,598,519 (New Position) |
Filing History |